RxSight, Inc.
For the period ended Sep 30, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 3, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Arrangements
During our last fiscal quarter, none of our directors or officers, as defined in Rule 16a-1(f), adoptedand/orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408.
Raymond Cohen – Consulting Agreement
On August 13, 2026, we entered into a Consulting Agreement with Raymond Cohen, a former director, to provide certain consulting and advisory services to us. Under the Consulting Agreement, we agreed to grant to Mr. Cohen an award of 12,000 restricted stock units which vests in equal installments over six months, subject to continuing service. The Consulting Agreement has a term of six months unless earlier terminated by either party with 10 days’ prior written notice.
Shelley Thunen – Consulting Termination
On September 30, 2026, we terminated the Consulting Agreement dated January 9, 2026 with Shelley Thunen, our former Chief Financial Officer.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.